Brokers Ratings on: Pacific Biosciences of California inc (NASDAQ:PACB)

5

Pacific Biosciences of California inc (NASDAQ:PACB) currently has a “Buy” signals on Composite indicators by TrendSpotter. While the Short-Term Technical Indicators for the stock on 7-Day Average Directional Indicator shows “Buy” signal. 10 – 8 Day Moving Average Hilo Channel shows “Buy” signal. While 20-Day Moving Average VS Current Price shows “Buy” Signal.

Pacific Biosciences of California inc (NASDAQ:PACB) gained 4.44 Percent and closed its previous trading session at $4.23. The stock traded with the average Volume of 881.04 Million at the end of last session.

Pacific Biosciences of California inc (NASDAQ:PACB) has the Market Capitalization of 554.89 Million. The Stock has its 52-week High of $5.70 and 52-Week Low of $2.02 and it touched its 52-week high on 09/12/17 and 52-Week Low on 04/02/18

.

The company reported its last earnings Actual EPS of $-0.17/share. While, the analyst predicted that the company could provide an EPS of $-0.17/share.

Sell side analysts plays vital role in buying and selling a stock where 0 analysts rated Pacific Biosciences of California inc (NASDAQ:PACB) as Buy, 0 analysts given Outperform signal, 1 reported Hold, and 0 analysts rated the stock as Sell.

The stock’s current distance from 20-Day Simple Moving Average (SMA20) is 11.65% where SMA50 and SMA200 are 19.99% and 44.12% respectively.

The company shows its Return on Assets (ROA) value of -57.9%. The Return on Equity (ROE) value stands at -90.8%. While it’s Return on Investment (ROI) value is -90.1%.

Pacific Biosciences of California inc (NASDAQ:PACB) currently has a Weekly Volatility of 9.80% percent while its Monthly Volatility is at 6.97% percent. While talking about Performance of the Stock, Pacific Biosciences of California inc currently has a Weekly performance of 9.02%, monthly performance percentage is 13.1 percent, Quarterly performance is 72.65 percent, 6 months performance shows a percent value of 67.19% and Yearly Performance is 6.55 percent.

Company Profile:

Pacific Biosciences of California, Inc. is engaged in the development, manufacture and commercialization of its single molecule, real-time, or SMRT technology-an integrated platform for genetic analysis. The SMRT technology uses the natural processing power of enzymes, combined with specially designed reagents and detection systems, to record individual biochemical events as they occur. The Company’s technology platform comprises of the SMRT cells, Phospholinked nucleotides and the PacBio RS (an instrument that conducts, monitors and analyzes single molecule biochemical reactions in real time). Its product will find its application in both research institutions and commercial companies, including genome centers, government and academic institutions, genomic service providers, pharmaceutical companies and agriculture companies. Pacific Biosciences of California, Inc. is headquartered in Menlo Park, California.

SHARE